Tvardi Therapeutics, Inc. · MUN:69C

Tvardi Therapeutics, Inc. shareholders

As of Sep 30, 2026, 60 institutions reported holding Tvardi Therapeutics, Inc., 27.1% of its shares. Largest: Slate Path Capital LP, Vanguard and Raymond James Financial Inc. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Tvardi Therapeutics, Inc.ChangeFiled
Slate Path Capital LP704K5.3%no changeNov 16, 2026
Vanguard420K3.1%+27,322Nov 13, 2026
Raymond James Financial Inc279K2.1%newNov 12, 2026
Two Sigma241K1.8%newNov 16, 2026
American Financial Group Inc224K1.7%no changeNov 12, 2026
JPMorgan202K1.5%+202KNov 12, 2026
Captrust Financial Advisors201K1.5%newNov 12, 2026
Renaissance Technologies134K1.0%+42,733Nov 12, 2026
Bank of America132K0.99%newNov 16, 2026
Geode Capital121K0.90%+30,292Nov 6, 2026

Tvardi Therapeutics, Inc. insider trades